stearylamine has been researched along with Leukemia, T-Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Imoto, K; Kaneko, M; Ohshika, H; Sakano, S; Takemura, H; Yamada, K | 1 |
1 other study(ies) available for stearylamine and Leukemia, T-Cell
Article | Year |
---|---|
Ca2+ mobilizing action of sphingosine in Jurkat human leukemia T cells. Evidence that sphingosine releases Ca2+ from inositol trisphosphate- and phosphatidic acid-sensitive intracellular stores through a mechanism independent of inositol trisphosphate.
Topics: Amines; Calcium; Cell Line; Ceramides; Diacylglycerol Kinase; Diglycerides; Enzyme Inhibitors; Humans; Inositol 1,4,5-Trisphosphate; Kinetics; Leukemia, T-Cell; Models, Biological; Muromonab-CD3; Phosphatidic Acids; Phosphotransferases (Alcohol Group Acceptor); Psychosine; Pyrimidinones; Sphingosine; Terpenes; Thapsigargin; Thiazoles; Tumor Cells, Cultured | 1996 |